Related references
Note: Only part of the references are listed.Natural compounds for pediatric cancer treatment
Veronica Ferrucci et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2016)
Update on Survival in Osteosarcoma
Megan E. Anderson
ORTHOPEDIC CLINICS OF NORTH AMERICA (2016)
Anticancer Molecular Mechanisms of Resveratrol
Elena M. Varoni et al.
FRONTIERS IN NUTRITION (2016)
Hairy/enhancer-of-split related with YRPW motif protein 1 promotes osteosarcoma metastasis via matrix metallopeptidase 9 expression
A. Tsuru et al.
BRITISH JOURNAL OF CANCER (2015)
PI3K/Akt signaling in osteosarcoma
Jian Zhang et al.
CLINICA CHIMICA ACTA (2015)
Wnt1-induced MAFK expression promotes osteosarcoma cell proliferation
R. Wang et al.
GENETICS AND MOLECULAR RESEARCH (2015)
Proinflammatory Cytokine IL-6 and JAK-STAT Signaling Pathway in Myeloproliferative Neoplasms
Vladan P. Cokic et al.
MEDIATORS OF INFLAMMATION (2015)
Identification of Novel Ezrin Inhibitors Targeting Metastatic Osteosarcoma by Screening Open Access Malaria Box
Haydar Celik et al.
MOLECULAR CANCER THERAPEUTICS (2015)
NKD2, a negative regulator of Wnt signaling, suppresses tumor growth and metastasis in osteosarcoma
S. Zhao et al.
ONCOGENE (2015)
P53 suppresses cell proliferation, metastasis, and angiogenesis of osteosarcoma through inhibition of the PI3K/AKT/mTOR pathway
Ruipeng Song et al.
INTERNATIONAL JOURNAL OF SURGERY (2015)
MUC16-mediated activation of mTOR and c-MYC reprograms pancreatic cancer metabolism
Surendra K. Shukla et al.
ONCOTARGET (2015)
Bone Sarcomas in Pediatrics: Progress in Our Understanding of Tumor Biology and Implications for Therapy
Rocio K. Rivera-Valentin et al.
PEDIATRIC DRUGS (2015)
MEK and PI3K inhibition in solid tumors: rationale and evidence to date
E. Jokinen et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2015)
Hedgehog Signaling Inhibitors as Anti-Cancer Agents in Osteosarcoma
Ram Mohan Ram Kumar et al.
CANCERS (2015)
5,7-Dihydroxy-4′-methoxyisoflavone induces apoptosis by inhibiting the ERK and Akt pathways in human osteosarcoma cells
Xiaosheng Lu et al.
CONNECTIVE TISSUE RESEARCH (2015)
Sulforaphane Bioavailability from Glucoraphanin-Rich Broccoli: Control by Active Endogenous Myrosinase
Jed W. Fahey et al.
PLOS ONE (2015)
Antitumor Effect of Docetaxel in Osteosarcoma by the Inhibition of Wnt Signal Channel
D. -Z. Wang et al.
DRUG RESEARCH (2015)
Recent advances in osteosarcoma
Sander M. Botter et al.
CURRENT OPINION IN PHARMACOLOGY (2014)
Cyclopamine: From Cyclops Lambs to Cancer Treatment
Stephen T. Lee et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2014)
Sulforaphane Induces DNA Damage and Mitotic Abnormalities in Human Osteosarcoma MG-63 Cells: Correlation with Cell Cycle Arrest and Apoptosis
Jose Miguel P. Ferreira de Oliveira et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2014)
Curcumin induces osteosarcoma MG63 cells apoptosis via ROS/Cyto-C/Caspase-3 pathway
Zhengqi Chang et al.
TUMOR BIOLOGY (2014)
Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of osteosarcoma cells by switching on suppressor microRNAs and inactivating of Notch-1 signaling
Yonggang Li et al.
CARCINOGENESIS (2013)
MicroRNA-199b-5p is involved in the Notch signaling pathway in osteosarcoma
Kyu Yeoun Won et al.
HUMAN PATHOLOGY (2013)
Novel strategies targeting cancer stem cells through phytochemicals and their analogs
Prasad Dandawate et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2013)
STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma
Bing Tu et al.
CANCER LETTERS (2012)
Curcumin inhibits proliferation and invasion of osteosarcoma cells through inactivation of Notch-1 signaling
Yonggang Li et al.
FEBS JOURNAL (2012)
Tumor-Derived Jagged1 Promotes Osteolytic Bone Metastasis of Breast Cancer by Engaging Notch Signaling in Bone Cells
Nilay Sethi et al.
CANCER CELL (2011)
Wnt10b Activates the Wnt, Notch, and NFκB Pathways in U2OS Osteosarcoma Cells
Ulrike I. Moedder et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Wnt signal transduction pathways
Yuko Komiya et al.
Organogenesis (2010)
The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism
Raphael Kopan et al.
CELL (2009)
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
Bryan T. MacDonald et al.
DEVELOPMENTAL CELL (2009)
Notch signaling contributes to the pathogenesis of human osteosarcomas
Feyza Engin et al.
HUMAN MOLECULAR GENETICS (2009)
Osteosarcoma
Patrick J. Messerschmitt et al.
JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS (2009)
Resveratrol induces senescence-like growth inhibition of U-2 OS cells associated with the instability of telomeric DNA and upregulation of BRCA1
Marek Rusin et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2009)
High Grade Osteosarcoma of the Extremities With Lung Metastases at Presentation: Treatment With Neoadjuvant Chemotherapy and Simultaneous Resection of Primary and Metastatic Lesions
Gaetano Bacci et al.
JOURNAL OF SURGICAL ONCOLOGY (2008)
Active γ-secretase complexes contain only one of each component
Toru Sato et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Osteosarcoma (Osteogenic sarcoma)
Piero Picci
ORPHANET JOURNAL OF RARE DISEASES (2007)
Osteosarcoma - Anatomic and histologic variants
MJ Klein et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2006)
Recent insights into the role of Notch signaling in tumorigenesis
KG Leong et al.
BLOOD (2006)
Mutations in NOTCH1 cause aortic valve disease
V Garg et al.
NATURE (2005)
Hedgehog signalling in colorectal tumour cells: Induction of apoptosis with cyclopamine treatment
D Qualtrough et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Notch signaling and inherited disease syndromes
T Gridley
HUMAN MOLECULAR GENETICS (2003)
Notch signaling: From the outside in
JS Mumm et al.
DEVELOPMENTAL BIOLOGY (2000)